| GTHX YTD Return Table | ||||||||||||||||||||||||||||||
GTHX YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Use our YTD Return Calculator to
compare GTHX YTD return versus benchmarks: YTD Return for S&P YTD Return for Dow YTD Return for Nasdaq 100 YTD Return for Russell 2000 YTD Return for Gold YTD Return for 10 Year Treasury |
| GTHX Share Performance |
| GTHX YTD Return Chart | |||
Also see: GTHX Average Annual Return | |||
| About G1 Therapeutics Inc |
| G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. Co.'s primary compound trilaciclib is a therapy designed to help protect against chemotherapy-induced myelosuppression. Trilaciclib helps protect hematopoietic stem and progenitor cells in the bone marrow by transiently inhibiting CDK4/6 leading to a temporary arrest of susceptible host cells during chemotherapy in patients. Rintodestrant is an oral selective estrogen receptor degrader for the treatment of ER+ breast cancer. The GTHX YTD return is shown above.
The YTD Return on the GTHX YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether GTHX YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the GTHX YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| GTHX Current Stock Quote |
 Free GTHX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| G1 Therapeutics (GTHX) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
GTS YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.
Video: Don't Forget Dividends in YTD Return!